Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 8/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19998010 | 0.88 | EGFR (0.46) | EGFRALDH1A1KDM4EHPGDLMNA | |
| SCHEMBL19998011 | 0.86 | EGFR (0.44) | EGFRALDH1A1KDM4EHPGDLMNA | |
| SCHEMBL19986133 | 0.85 | TOP1 (0.42) | TOP1EGFRALDH1A1KDM4EHPGD | |
| SCHEMBL19985982 | 0.85 | TOP1 (0.42) | TOP1EGFRALDH1A1KDM4EHPGD | |
| SCHEMBL19986203 | 0.84 | TOP1 (0.41) | TOP1EGFRALDH1A1KDM4EHPGD | |
| SCHEMBL19986010 | 0.84 | TOP1 (0.41) | TOP1EGFRALDH1A1KDM4EHPGD | |
| SCHEMBL19997999 | 0.81 | EGFR (0.38) | EGFRALDH1A1KDM4EHPGDLMNA | |
| SCHEMBL19986134 | 0.80 | TOP1 (0.37) | TOP1 | |
| SCHEMBL19986024 | 0.80 | TOP1 (0.37) | TOP1 | |
| SCHEMBL19988464 | 0.78 | TOP1 (0.43) | TOP1EGFRALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10032999-B2 | Compound for organic optoelectric device, composition for organic optoelectric device and organic optoelectric device and display device | SAMSUNG SDI CO., LTD. (KR) | 2018-07-24 | — | — | US | disclosed |
| US-20180090690-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10032999-B2 | Compound for organic optoelectric device, composition for organic optoelectric device and organic optoelectric device and display device | OXER1, OCIAD1, OR10J3 | TOP1 3587/4885EGFR 1144/4885ALDH1A1 57/4885 |
| US-20180090690-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | OXER1, OCIAD1, OR10J3 | TOP1 3587/4885EGFR 1144/4885ALDH1A1 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.